http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2167664-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b8461be492829469685ac6da687e2c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0ad073a3abf25b5f8bbfba0e1508031 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 |
filingDate | 1998-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2001-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a85574624556b2ad023cba4e0fc93ceb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56add992e0b218b31a3fb4a712eba848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87a7a5ea8c5aa61c9618f06b5360ae93 |
publicationDate | 2001-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2167664-C2 |
titleOfInvention | Anti-inflammatory and immunomodulating agent |
abstract | FIELD: medicine. SUBSTANCE: anti-inflammatory and immunomodulating agent has a homogenate fraction of cut-off placental villi dissolved in 0.95% sodium chloride solution. Invention can be used for treatment of patients with autoimmune diseases, chronic and acute inflammatory diseases associated with noncontrolled activation of respiratory "burst" of neutrophils. Proposed agent shows the purposeful effect providing inhibition of respiratory "burst". EFFECT: enhanced effectiveness of agent. 4 ex |
priorityDate | 1998-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727 |
Total number of triples: 16.